According to United Nations data, by 2050, nearly one in every six people is expected to be at least 65 years old (compared to only one in 20 in 1950), and the rate of growth in that age group is triple that of the overall population, triggering
an unprecedented need for treatment of age - related morbidities.
Canine and human comparisons represent an
unprecedented opportunity to complement conventional endocrine tumour research paradigms, addressing a devastating group of cancers
for which innovative diagnostic and
treatment strategies are clearly
needed.